Popular Categories
Previous article![]( "I Believe in the Improvement of Iran’s Pharmaceutical Landscape")
Next article![]( "US FDA to revise label of ADHD stimulants to add weight loss risk in patients younger than 6")
about fansalaran
FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.
Rebalancing Skin Care Products Market Gains Momentum Across APAC, Europe, USA, and Saudi Arabia Driven by Personal Care
The global skin care industry is entering a decisive...
Takeda deepens AI drug discovery push with $1.7 billion Iambic deal
Privately held Iambic said on Monday it has entered...
Lilly bets on next-generation cell therapy with $2.4 billion deal for Orna
Eli Lilly will buy Orna Therapeutics for up to...
US FDA says Novo’s obesity pill TV Ad is false or misleading
The U.S. Food and Drug Administration said a television...
Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia
Sanofi’s rilzabrutinib designated breakthrough therapy in the US and...
Rebalancing Skin Care Products Market Gains Momentum Across APAC, Europe, USA, and Saudi Arabia Driven by Personal Care
The global skin care industry is entering a decisive...
Takeda deepens AI drug discovery push with $1.7 billion Iambic deal
Privately held Iambic said on Monday it has entered...
Lilly bets on next-generation cell therapy with $2.4 billion deal for Orna
Eli Lilly will buy Orna Therapeutics for up to...
US FDA says Novo’s obesity pill TV Ad is false or misleading
The U.S. Food and Drug Administration said a television...
Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia
Sanofi’s rilzabrutinib designated breakthrough therapy in the US and...
Rebalancing Skin Care Products Market Gains Momentum Across APAC, Europe, USA, and Saudi Arabia Driven by Personal Care
The global skin care industry is entering a decisive...
Takeda deepens AI drug discovery push with $1.7 billion Iambic deal
Privately held Iambic said on Monday it has entered...
Lilly bets on next-generation cell therapy with $2.4 billion deal for Orna
Eli Lilly will buy Orna Therapeutics for up to...
US FDA says Novo’s obesity pill TV Ad is false or misleading
The U.S. Food and Drug Administration said a television...
Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia
Sanofi’s rilzabrutinib designated breakthrough therapy in the US and...
Rebalancing Skin Care Products Market Gains Momentum Across APAC, Europe, USA, and Saudi Arabia Driven by Personal Care
The global skin care industry is entering a decisive...
Takeda deepens AI drug discovery push with $1.7 billion Iambic deal
Privately held Iambic said on Monday it has entered...
Lilly bets on next-generation cell therapy with $2.4 billion deal for Orna
Eli Lilly will buy Orna Therapeutics for up to...
US FDA says Novo’s obesity pill TV Ad is false or misleading
The U.S. Food and Drug Administration said a television...
Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia
Sanofi’s rilzabrutinib designated breakthrough therapy in the US and...
"Fansalaran showcases the latest news and the top pharmaceutical brands in the country. With Fansalaran, you can be seen globally."
Headlines
Rebalancing Skin Care Products Market Gains Momentum Across APAC, Europe, USA, and Saudi Arabia Driven by Personal Care
The global skin care industry is entering a decisive...
Takeda deepens AI drug discovery push with $1.7 billion Iambic deal
Privately held Iambic said on Monday it has entered...
Lilly bets on next-generation cell therapy with $2.4 billion deal for Orna
Eli Lilly will buy Orna Therapeutics for up to...
US FDA says Novo’s obesity pill TV Ad is false or misleading
The U.S. Food and Drug Administration said a television...
Fansalaran
Get important news delivered directly to your inbox and stay connected!